GLP-1 Drugs Like Ozempic May Reduce Violent Behavior Through Effects on Impulse Control, Study Suggests
A new study from Rutgers University suggests that GLP-1 drugs like Ozempic and Wegovy may be associated with a reduction in violent behavior. The research indicates these medications could weaken the link between impulsive tendencies and aggressive actions.
The findings are somewhat unexpected, as these weight-loss and diabetes drugs are not designed to address behavioral issues. However, researchers observed that people taking GLP-1 medications appeared less likely to act on impulsive urges that might otherwise lead to violent behavior.
The study authors caution that while the association is notable, cause and effect have not been proven. The research does not establish that the drugs directly prevent violence, only that there appears to be a correlation worth investigating further.
The mechanism behind this potential effect remains unclear. One hypothesis is that GLP-1 drugs may influence brain pathways involved in reward processing and impulse control, though more research would be needed to confirm this.
Researchers stress that these are preliminary findings and should not change how these medications are prescribed. The drugs are approved for treating diabetes and weight management, and any potential effects on behavior would be considered secondary at this stage.